Quick Answer
ANI PHARMACEUTICALS INC reported Net Income of $78.34 million for fiscal year 2025.
ANI PHARMACEUTICALS INC Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | $78.34M | +522.9% |
| 2024 | -$18.52M | -198.6% |
| 2023 | $18.78M | +139.2% |
| 2022 | -$47.90M | -12.4% |
| 2021 | -$42.60M | -88.9% |
| 2020 | -$22.55M | -470.0% |
| 2019 | $6.09M | -60.7% |
| 2018 | $15.49M | +1540.0% |
| 2017 | -$1.08M | -127.4% |
| 2016 | $3.93M | -74.4% |
| 2015 | $15.38M | -46.5% |
| 2014 | $28.75M | +9450.5% |
| 2013 | $301.0K | +120.0% |
| 2012 | -$1.51M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $26.62M | +210.1% | +211.3% |
| June 30, 2025 | $8.55M | +473.8% | -45.5% |
| March 31, 2025 | $15.68M | -13.9% | +164.9% |
| September 30, 2024 | -$24.17M | -343.1% | -956.7% |
| June 30, 2024 | -$2.29M | -136.6% | -112.6% |
| March 31, 2024 | $18.21M | +1165.3% | +83.2% |
| September 30, 2023 | $9.94M | +215.6% | +59.2% |
| June 30, 2023 | $6.25M | +141.8% | +334.0% |
- ANI PHARMACEUTICALS INC showed an increase of +522.9% in Net Income compared to the prior fiscal year.
- Over the 2012–2025 period, ANI PHARMACEUTICALS INC’s net income has grown by 5301.7% (from -$1.51 million to $78.34 million).
- The most recent figure is from ANI PHARMACEUTICALS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: